Monday, May 20, 2024 | Baltimore, MD

Merck debuts new genetic stability process to accelerate biopharmaceutical testing

April 18, 2024
Photo captured during office hours of a company in Brazil.

Merck, a leading global technology company with a U.S. laboratory in Rockville, launched the Aptegra CHO Genetic Stability Assay, which leverages whole-genome sequencing and bioinformatics to significantly accelerate customers’ biopharmaceutical safety testing, thereby helping to accelerate customers’ entry into commercial production.

Article Source: The Daily Record

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.